Annual report pursuant to Section 13 and 15(d)

Note 2 - Patents

v2.4.1.9
Note 2 - Patents
12 Months Ended
Dec. 31, 2014
Notes to Financial Statements  
Note 2 - Patents

 

             
    December 31, 2014     December 31, 2013  
Capitalized patent costs   $ 642,0000     $ 642,000  
Accumulated amortization     (642,000)       (620,000)  
    $ -     $ 22,000  


Periodically, the Company reviews its patent portfolio and has determined that certain patent applications no longer possessed commercial viability or were abandoned since they were inconsistent with the Company's business development strategy.